Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP1 Transition Trial
NCT06605703Phase 4Completed
- Sponsor
- WW International
- Start
- Sep 2024
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bupropion, naltrexone, metformin in obesity, Overweight, sponsored by WW International. Started Sep 2024; status: completed.
02
Drugs
bupropionnaltrexonemetformin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT06605703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06605703.